Complexa Competitors and Similar CompaniesClear all
Immatics's competitors and similar companies include Synthorx.
 Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. |  Synthorx Synthorx is a biotechnology company using synthetic biology starting with its novel DNA base pair to discover and develop new protein therapeutics. | |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US | Locations San Diego, US HQ |
Employees | Employees 29723% increase | Employees 3939% increase |
Valuation ($) | Valuation ($) 1.1 b | Valuation ($) 2.2 b |
Financial | ||
Net income | Net income (€196.4m) (FY, 2025) | Net income ($5.9m) (FY, 2017) |
Funding | ||
Total funding raised | Total funding raised $ 267.3m | Total funding raised $ 79m |
For sources of this data, please see the company profile
View Company Profiles
Synthorx
HQ
San Diego, US
Employees
39↑ 39% increase
Synthorx is a biotechnology company using synthetic biology starting with its novel DNA base pair to discover and develop new protein therapeutics.
View company